| Fabino Life Sciences Ltd |
|
Registered Office:
105 1st Floor Barodia Tower,Central Market Prashant Vihar
,
New Delhi
-
110085
,
New Delhi
, India.
Phone :
+91-988390021/9215324221 Fax:
Email : info@fabinolife.com
Website : www.fabinolife.com
|
Initial public issue of 9,00,000 equity shares of  10 each ("Equity Shares") of Fabino Life Sciences Limited (FLSL" or the "Company") for cash at a price of 36 per share (The "Issue Price"), aggregating to 3.24 crores ("The Issue"), of which 48,000 equity shares of 10 each will be reserved for subscription by market maker to the issue (The "Market Maker Reservation Portion"). The issue less market maker reservation portion i.e. issue of 8,52,000 equity shares of 10 each is hereinafter referred to as the "Net Issue". The issue and the net issue will constitute 42.86% and 40.57%, respectively of the post issue paid up equity share capital of the company.
The the face value of the equity share is 10/- and the issue price is 3.6 times of the face value.
Bids can be made for a minimum of 3000 equity shares and in multiples of
3000 equity shares thereafter. |
| Issue |
Money Payable On |
|
| Opens On |
Closes On |
Application |
Allotment |
|
| 31-Dec-21 |
05-Jan-22 |
Rs36.00-0.00 |
Rs0.00-0.00 |
| Minimum Application for shares in Nos :3000 Further Multiples of :3000 |
| |
RsCr |
Lead Managers to the Issue |
|
| Project Cost |
3.24 |
| Aryaman Financial Services Ltd |
|
| Project Financed through Current Offer |
3.24 |
|
| Post Issue Equity Share Capital |
2.10 |
|
| Issue Price |
Rs36.00 |
|
|